CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | STARR CHRISTOPHER M Director | Grant or award · Restricted Stock Units | +1,289 | 1,289 | ||
| 2020-01-31 | STARR CHRISTOPHER M Director | Grant or award · Stock Options | +5,646 | 5,646 | ||
| 2020-01-31 | Robinson Chandler Chief Executive Officer | Grant or award · Restricted Stock Units | +26,895 | 26,895 | ||
| 2020-01-31 | Robinson Chandler Chief Executive Officer | Grant or award · Stock Options | +111,753 | 111,753 | ||
| 2020-01-31 | Anderson Raymond Director | Grant or award · Restricted Stock Units | +1,289 | 1,289 | ||
| 2020-01-31 | Anderson Raymond Director | Grant or award · Stock Options | +5,646 | 5,646 | ||
| 2020-01-31 | Mazar Andrew Paul Chief Scientific Officer | Grant or award · Restricted Stock Units | +7,748 | 7,748 | ||
| 2020-01-31 | Mazar Andrew Paul Chief Scientific Officer | Grant or award · Stock Options | +32,193 | 32,193 | ||
| 2020-01-31 | KLAUSNER ARTHUR J Director | Grant or award · Restricted Stock Units | +1,289 | 1,289 | ||
| 2020-01-31 | KLAUSNER ARTHUR J Director | Grant or award · Stock Options | +5,646 | 5,646 | ||
| 2020-01-30 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock Options | +6,125 | 6,125 | ||
| 2019-12-18 | Hendricks Diane 10% owner | Purchase | +468,750 | $8.00 | $3.8M | 468,750 |
| 2019-12-18 | Tactic Pharma LLC 10% owner | Purchase | +125,000 | $8.00 | $1.0M | 291,667 |
| 2019-12-18 | Leo Karl 10% owner | Purchase | +156,250 | $8.00 | $1.3M | 156,250 |
| 2019-12-18 | Leo Karl 10% owner | Purchase | +313.75 | $8.00 | $3K | 313.75 |
| 2019-12-18 | Tsuchimoto Kim R Chief Financial Officer | Purchase | +325 | $8.00 | $3K | 325 |
| 2019-11-26 | RIOUX PATRICE Acting Chief Medical Officer | Exercise or conversion | +18,333 | $6.00 | $110K | 18,333 |
| 2019-11-26 | RIOUX PATRICE Acting Chief Medical Officer | Exercise or conversion | +100 | $0.00 | $0 | 18,433 |
| 2019-11-26 | RIOUX PATRICE Acting Chief Medical Officer | Exercise or conversion · Stock options | −18,333 | 13,671 | ||
| 2019-11-26 | RIOUX PATRICE Acting Chief Medical Officer | Exercise or conversion · Stock options | −100 | 6,900 |
Page 27 of 28 · 549 trades